Industry Research Reports
Home > Reports > Pharma & Healthcare > Colloids (Blood Plasma)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Colloids (Blood Plasma)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Industry: Pharma & Healthcare
Published Date: 2025-01-16
Pages: 157 Pages
Report ld: 3478147
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Colloids (Blood Plasma) Market Size(US$)
CAGR 2025-2031
-2.5%
Market Size,2031
USD 325
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 378 million
Market Forecast in 2031(Value)
US$ 325 million
CAGR
-2.5%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Colloids (Blood Plasma) was estimated to be worth US$ 387 million in 2024 and is forecast to a readjusted size of US$ 325 million by 2031 with a CAGR of -2.5% during the forecast period 2025-2031.
Colloids (blood plasma) are the substances of expanding the circulating blood volume, which mainly contain albumin type, gelatin type, dextran type and hydroxyethyl starch type.
Colloids (Blood Plasma) can be applied for extensive burns, massive blood or plasma loss and hypovolemic shock. In this report, we calculate colloids (blood plasma) preparations, which is produced by albumin, gelatin, dextran and hydroxyethyl starch.
North America is the largest Colloids (Blood Plasma) market with about 33% market share. Europe is follower, accounting for about 28% market share.
The key players are CSL Behring, Baxter, Grifols, Octapharma, Kedrion, Shanghai Raas, CTBB, Hualan Bio, Rongsheng Pharmaceutical, Boya Rongsheng, B. Braun Medical, Fresenius Kabi, HOSPIRA, Axa parenterals, Fresenius Kabi(China), CR Double-Crane, Kelun Group, Shandong Qidu Pharmaceutical, Shandong Hualu Pharmaceutical, Minsheng Pharma, Kanglepharm etc. Top 3 companies occupied about 46% market share.
This report aims to provide a comprehensive presentation of the global market for Colloids (Blood Plasma), focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Colloids (Blood Plasma) by region & country, by Type, and by Application.
The Colloids (Blood Plasma) market size, estimations, and forecasts are provided in terms of sales volume (MT) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Colloids (Blood Plasma).
MARKET SEGMENTATION
By Company
- CSL Behring
- Baxter
- Grifols
- Octapharma
- Kedrion
- Shanghai Raas
- CTBB
- Hualan Bio
- Rongsheng Pharmaceutical
- Boya Rongsheng
- B. Braun Medical
- Fresenius Kabi
- HOSPIRA
- Axa parenterals
- Fresenius Kabi (China)
- CR Double-Crane
- Kelun Group
- Shandong Qidu Pharmaceutical
- Shandong Hualu Pharmaceutical
- Minsheng Pharma
- Kanglepharm
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Natural Type Colloids (Blood Plasma)
- Synthetic Type Colloids (Blood Plasma)
Segment by Application
- Extensive Burns
- Massive Blood or Plasma Loss
- Hypovolemic Shock
- Others
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Colloids (Blood Plasma) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Colloids (Blood Plasma) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Colloids (Blood Plasma) in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Colloids (Blood Plasma) Product Introduction
1.2 Global Colloids (Blood Plasma) Market Size Forecast
1.2.1 Global Colloids (Blood Plasma) Sales Value (2020-2031)
1.2.2 Global Colloids (Blood Plasma) Sales Volume (2020-2031)
1.2.3 Global Colloids (Blood Plasma) Sales Price (2020-2031)
1.3 Colloids (Blood Plasma) Market Trends & Drivers
1.3.1 Colloids (Blood Plasma) Industry Trends
1.3.2 Colloids (Blood Plasma) Market Drivers & Opportunity
1.3.3 Colloids (Blood Plasma) Market Challenges
1.3.4 Colloids (Blood Plasma) Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Colloids (Blood Plasma) Players Revenue Ranking (2024)
2.2 Global Colloids (Blood Plasma) Revenue by Company (2020-2025)
2.3 Global Colloids (Blood Plasma) Players Sales Volume Ranking (2024)
2.4 Global Colloids (Blood Plasma) Sales Volume by Company Players (2020-2025)
2.5 Global Colloids (Blood Plasma) Average Price by Company (2020-2025)
2.6 Key Manufacturers Colloids (Blood Plasma) Manufacturing Base and Headquarters
2.7 Key Manufacturers Colloids (Blood Plasma) Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Colloids (Blood Plasma)
2.9 Colloids (Blood Plasma) Market Competitive Analysis
2.9.1 Colloids (Blood Plasma) Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Colloids (Blood Plasma) Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Colloids (Blood Plasma) as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Natural Type Colloids (Blood Plasma)
3.1.2 Synthetic Type Colloids (Blood Plasma)
3.2 Global Colloids (Blood Plasma) Sales Value by Type
3.2.1 Global Colloids (Blood Plasma) Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Colloids (Blood Plasma) Sales Value, by Type (2020-2031)
3.2.3 Global Colloids (Blood Plasma) Sales Value, by Type (%) (2020-2031)
3.3 Global Colloids (Blood Plasma) Sales Volume by Type
3.3.1 Global Colloids (Blood Plasma) Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Colloids (Blood Plasma) Sales Volume, by Type (2020-2031)
3.3.3 Global Colloids (Blood Plasma) Sales Volume, by Type (%) (2020-2031)
3.4 Global Colloids (Blood Plasma) Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Extensive Burns
4.1.2 Massive Blood or Plasma Loss
4.1.3 Hypovolemic Shock
4.1.4 Others
4.2 Global Colloids (Blood Plasma) Sales Value by Application
4.2.1 Global Colloids (Blood Plasma) Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Colloids (Blood Plasma) Sales Value, by Application (2020-2031)
4.2.3 Global Colloids (Blood Plasma) Sales Value, by Application (%) (2020-2031)
4.3 Global Colloids (Blood Plasma) Sales Volume by Application
4.3.1 Global Colloids (Blood Plasma) Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Colloids (Blood Plasma) Sales Volume, by Application (2020-2031)
4.3.3 Global Colloids (Blood Plasma) Sales Volume, by Application (%) (2020-2031)
4.4 Global Colloids (Blood Plasma) Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Colloids (Blood Plasma) Sales Value by Region
5.1.1 Global Colloids (Blood Plasma) Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Colloids (Blood Plasma) Sales Value by Region (2020-2025)
5.1.3 Global Colloids (Blood Plasma) Sales Value by Region (2026-2031)
5.1.4 Global Colloids (Blood Plasma) Sales Value by Region (%), (2020-2031)
5.2 Global Colloids (Blood Plasma) Sales Volume by Region
5.2.1 Global Colloids (Blood Plasma) Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Colloids (Blood Plasma) Sales Volume by Region (2020-2025)
5.2.3 Global Colloids (Blood Plasma) Sales Volume by Region (2026-2031)
5.2.4 Global Colloids (Blood Plasma) Sales Volume by Region (%), (2020-2031)
5.3 Global Colloids (Blood Plasma) Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Colloids (Blood Plasma) Sales Value, 2020-2031
5.4.2 North America Colloids (Blood Plasma) Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Colloids (Blood Plasma) Sales Value, 2020-2031
5.5.2 Europe Colloids (Blood Plasma) Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Colloids (Blood Plasma) Sales Value, 2020-2031
5.6.2 Asia Pacific Colloids (Blood Plasma) Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Colloids (Blood Plasma) Sales Value, 2020-2031
5.7.2 South America Colloids (Blood Plasma) Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Colloids (Blood Plasma) Sales Value, 2020-2031
5.8.2 Middle East & Africa Colloids (Blood Plasma) Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Colloids (Blood Plasma) Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Colloids (Blood Plasma) Sales Value
6.2.1 Key Countries/Regions Colloids (Blood Plasma) Sales Value, 2020-2031
6.2.2 Key Countries/Regions Colloids (Blood Plasma) Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Colloids (Blood Plasma) Sales Value, 2020-2031
6.3.2 United States Colloids (Blood Plasma) Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Colloids (Blood Plasma) Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Colloids (Blood Plasma) Sales Value, 2020-2031
6.4.2 Europe Colloids (Blood Plasma) Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Colloids (Blood Plasma) Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Colloids (Blood Plasma) Sales Value, 2020-2031
6.5.2 China Colloids (Blood Plasma) Sales Value by Type (%), 2024 VS 2031
6.5.3 China Colloids (Blood Plasma) Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Colloids (Blood Plasma) Sales Value, 2020-2031
6.6.2 Japan Colloids (Blood Plasma) Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Colloids (Blood Plasma) Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Colloids (Blood Plasma) Sales Value, 2020-2031
6.7.2 South Korea Colloids (Blood Plasma) Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Colloids (Blood Plasma) Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Colloids (Blood Plasma) Sales Value, 2020-2031
6.8.2 Southeast Asia Colloids (Blood Plasma) Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Colloids (Blood Plasma) Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Colloids (Blood Plasma) Sales Value, 2020-2031
6.9.2 India Colloids (Blood Plasma) Sales Value by Type (%), 2024 VS 2031
6.9.3 India Colloids (Blood Plasma) Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 CSL Behring
7.1.1 CSL Behring Company Information
7.1.2 CSL Behring Introduction and Business Overview
7.1.3 CSL Behring Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 CSL Behring Colloids (Blood Plasma) Product Offerings
7.1.5 CSL Behring Recent Development
7.2 Baxter
7.2.1 Baxter Company Information
7.2.2 Baxter Introduction and Business Overview
7.2.3 Baxter Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Baxter Colloids (Blood Plasma) Product Offerings
7.2.5 Baxter Recent Development
7.3 Grifols
7.3.1 Grifols Company Information
7.3.2 Grifols Introduction and Business Overview
7.3.3 Grifols Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Grifols Colloids (Blood Plasma) Product Offerings
7.3.5 Grifols Recent Development
7.4 Octapharma
7.4.1 Octapharma Company Information
7.4.2 Octapharma Introduction and Business Overview
7.4.3 Octapharma Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Octapharma Colloids (Blood Plasma) Product Offerings
7.4.5 Octapharma Recent Development
7.5 Kedrion
7.5.1 Kedrion Company Information
7.5.2 Kedrion Introduction and Business Overview
7.5.3 Kedrion Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Kedrion Colloids (Blood Plasma) Product Offerings
7.5.5 Kedrion Recent Development
7.6 Shanghai Raas
7.6.1 Shanghai Raas Company Information
7.6.2 Shanghai Raas Introduction and Business Overview
7.6.3 Shanghai Raas Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Shanghai Raas Colloids (Blood Plasma) Product Offerings
7.6.5 Shanghai Raas Recent Development
7.7 CTBB
7.7.1 CTBB Company Information
7.7.2 CTBB Introduction and Business Overview
7.7.3 CTBB Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 CTBB Colloids (Blood Plasma) Product Offerings
7.7.5 CTBB Recent Development
7.8 Hualan Bio
7.8.1 Hualan Bio Company Information
7.8.2 Hualan Bio Introduction and Business Overview
7.8.3 Hualan Bio Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Hualan Bio Colloids (Blood Plasma) Product Offerings
7.8.5 Hualan Bio Recent Development
7.9 Rongsheng Pharmaceutical
7.9.1 Rongsheng Pharmaceutical Company Information
7.9.2 Rongsheng Pharmaceutical Introduction and Business Overview
7.9.3 Rongsheng Pharmaceutical Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Rongsheng Pharmaceutical Colloids (Blood Plasma) Product Offerings
7.9.5 Rongsheng Pharmaceutical Recent Development
7.10 Boya Rongsheng
7.10.1 Boya Rongsheng Company Information
7.10.2 Boya Rongsheng Introduction and Business Overview
7.10.3 Boya Rongsheng Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Boya Rongsheng Colloids (Blood Plasma) Product Offerings
7.10.5 Boya Rongsheng Recent Development
7.11 B. Braun Medical
7.11.1 B. Braun Medical Company Information
7.11.2 B. Braun Medical Introduction and Business Overview
7.11.3 B. Braun Medical Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 B. Braun Medical Colloids (Blood Plasma) Product Offerings
7.11.5 B. Braun Medical Recent Development
7.12 Fresenius Kabi
7.12.1 Fresenius Kabi Company Information
7.12.2 Fresenius Kabi Introduction and Business Overview
7.12.3 Fresenius Kabi Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 Fresenius Kabi Colloids (Blood Plasma) Product Offerings
7.12.5 Fresenius Kabi Recent Development
7.13 HOSPIRA
7.13.1 HOSPIRA Company Information
7.13.2 HOSPIRA Introduction and Business Overview
7.13.3 HOSPIRA Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2020-2025)
7.13.4 HOSPIRA Colloids (Blood Plasma) Product Offerings
7.13.5 HOSPIRA Recent Development
7.14 Axa parenterals
7.14.1 Axa parenterals Company Information
7.14.2 Axa parenterals Introduction and Business Overview
7.14.3 Axa parenterals Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2020-2025)
7.14.4 Axa parenterals Colloids (Blood Plasma) Product Offerings
7.14.5 Axa parenterals Recent Development
7.15 Fresenius Kabi (China)
7.15.1 Fresenius Kabi (China) Company Information
7.15.2 Fresenius Kabi (China) Introduction and Business Overview
7.15.3 Fresenius Kabi (China) Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2020-2025)
7.15.4 Fresenius Kabi (China) Colloids (Blood Plasma) Product Offerings
7.15.5 Fresenius Kabi (China) Recent Development
7.16 CR Double-Crane
7.16.1 CR Double-Crane Company Information
7.16.2 CR Double-Crane Introduction and Business Overview
7.16.3 CR Double-Crane Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2020-2025)
7.16.4 CR Double-Crane Colloids (Blood Plasma) Product Offerings
7.16.5 CR Double-Crane Recent Development
7.17 Kelun Group
7.17.1 Kelun Group Company Information
7.17.2 Kelun Group Introduction and Business Overview
7.17.3 Kelun Group Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2020-2025)
7.17.4 Kelun Group Colloids (Blood Plasma) Product Offerings
7.17.5 Kelun Group Recent Development
7.18 Shandong Qidu Pharmaceutical
7.18.1 Shandong Qidu Pharmaceutical Company Information
7.18.2 Shandong Qidu Pharmaceutical Introduction and Business Overview
7.18.3 Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2020-2025)
7.18.4 Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Product Offerings
7.18.5 Shandong Qidu Pharmaceutical Recent Development
7.19 Shandong Hualu Pharmaceutical
7.19.1 Shandong Hualu Pharmaceutical Company Information
7.19.2 Shandong Hualu Pharmaceutical Introduction and Business Overview
7.19.3 Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2020-2025)
7.19.4 Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Product Offerings
7.19.5 Shandong Hualu Pharmaceutical Recent Development
7.20 Minsheng Pharma
7.20.1 Minsheng Pharma Company Information
7.20.2 Minsheng Pharma Introduction and Business Overview
7.20.3 Minsheng Pharma Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2020-2025)
7.20.4 Minsheng Pharma Colloids (Blood Plasma) Product Offerings
7.20.5 Minsheng Pharma Recent Development
7.21 Kanglepharm
7.21.1 Kanglepharm Company Information
7.21.2 Kanglepharm Introduction and Business Overview
7.21.3 Kanglepharm Colloids (Blood Plasma) Sales, Revenue, Price and Gross Margin (2020-2025)
7.21.4 Kanglepharm Colloids (Blood Plasma) Product Offerings
7.21.5 Kanglepharm Recent Development
8 Industry Chain Analysis
8.1 Colloids (Blood Plasma) Industrial Chain
8.2 Colloids (Blood Plasma) Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Colloids (Blood Plasma) Sales Model
8.5.2 Sales Channel
8.5.3 Colloids (Blood Plasma) Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Colloids (Blood Plasma) Market Trends
Table 2. Colloids (Blood Plasma) Market Drivers & Opportunity
Table 3. Colloids (Blood Plasma) Market Challenges
Table 4. Colloids (Blood Plasma) Market Restraints
Table 5. Global Colloids (Blood Plasma) Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Colloids (Blood Plasma) Revenue Market Share by Company (2020-2025)
Table 7. Global Colloids (Blood Plasma) Sales Volume by Company (2020-2025) & (MT)
Table 8. Global Colloids (Blood Plasma) Sales Volume Market Share by Company (2020-2025)
Table 9. Global Market Colloids (Blood Plasma) Price by Company (2020-2025) & (USD/Kg)
Table 10. Key Manufacturers Colloids (Blood Plasma) Manufacturing Base and Headquarters
Table 11. Key Manufacturers Colloids (Blood Plasma) Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Colloids (Blood Plasma)
Table 13. Global Colloids (Blood Plasma) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Colloids (Blood Plasma) as of 2024)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Colloids (Blood Plasma) Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Colloids (Blood Plasma) Sales Value by Type (2020-2025) & (US$ Million)
Table 18. Global Colloids (Blood Plasma) Sales Value by Type (2026-2031) & (US$ Million)
Table 19. Global Colloids (Blood Plasma) Sales Market Share in Value by Type (2020-2025)
Table 20. Global Colloids (Blood Plasma) Sales Market Share in Value by Type (2026-2031)
Table 21. Global Colloids (Blood Plasma) Sales Volume by Type: 2020 VS 2024 VS 2031 (MT)
Table 22. Global Colloids (Blood Plasma) Sales Volume by Type (2020-2025) & (MT)
Table 23. Global Colloids (Blood Plasma) Sales Volume by Type (2026-2031) & (MT)
Table 24. Global Colloids (Blood Plasma) Sales Market Share in Volume by Type (2020-2025)
Table 25. Global Colloids (Blood Plasma) Sales Market Share in Volume by Type (2026-2031)
Table 26. Global Colloids (Blood Plasma) Price by Type (2020-2025) & (USD/Kg)
Table 27. Global Colloids (Blood Plasma) Price by Type (2026-2031) & (USD/Kg)
Table 28. Global Colloids (Blood Plasma) Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 29. Global Colloids (Blood Plasma) Sales Value by Application (2020-2025) & (US$ Million)
Table 30. Global Colloids (Blood Plasma) Sales Value by Application (2026-2031) & (US$ Million)
Table 31. Global Colloids (Blood Plasma) Sales Market Share in Value by Application (2020-2025)
Table 32. Global Colloids (Blood Plasma) Sales Market Share in Value by Application (2026-2031)
Table 33. Global Colloids (Blood Plasma) Sales Volume by Application: 2020 VS 2024 VS 2031 (MT)
Table 34. Global Colloids (Blood Plasma) Sales Volume by Application (2020-2025) & (MT)
Table 35. Global Colloids (Blood Plasma) Sales Volume by Application (2026-2031) & (MT)
Table 36. Global Colloids (Blood Plasma) Sales Market Share in Volume by Application (2020-2025)
Table 37. Global Colloids (Blood Plasma) Sales Market Share in Volume by Application (2026-2031)
Table 38. Global Colloids (Blood Plasma) Price by Application (2020-2025) & (USD/Kg)
Table 39. Global Colloids (Blood Plasma) Price by Application (2026-2031) & (USD/Kg)
Table 40. Global Colloids (Blood Plasma) Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 41. Global Colloids (Blood Plasma) Sales Value by Region (2020-2025) & (US$ Million)
Table 42. Global Colloids (Blood Plasma) Sales Value by Region (2026-2031) & (US$ Million)
Table 43. Global Colloids (Blood Plasma) Sales Value by Region (2020-2025) & (%)
Table 44. Global Colloids (Blood Plasma) Sales Value by Region (2026-2031) & (%)
Table 45. Global Colloids (Blood Plasma) Sales Volume by Region (MT): 2020 VS 2024 VS 2031
Table 46. Global Colloids (Blood Plasma) Sales Volume by Region (2020-2025) & (MT)
Table 47. Global Colloids (Blood Plasma) Sales Volume by Region (2026-2031) & (MT)
Table 48. Global Colloids (Blood Plasma) Sales Volume by Region (2020-2025) & (%)
Table 49. Global Colloids (Blood Plasma) Sales Volume by Region (2026-2031) & (%)
Table 50. Global Colloids (Blood Plasma) Average Price by Region (2020-2025) & (USD/Kg)
Table 51. Global Colloids (Blood Plasma) Average Price by Region (2026-2031) & (USD/Kg)
Table 52. Key Countries/Regions Colloids (Blood Plasma) Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 53. Key Countries/Regions Colloids (Blood Plasma) Sales Value, (2020-2025) & (US$ Million)
Table 54. Key Countries/Regions Colloids (Blood Plasma) Sales Value, (2026-2031) & (US$ Million)
Table 55. Key Countries/Regions Colloids (Blood Plasma) Sales Volume, (2020-2025) & (MT)
Table 56. Key Countries/Regions Colloids (Blood Plasma) Sales Volume, (2026-2031) & (MT)
Table 57. CSL Behring Company Information
Table 58. CSL Behring Introduction and Business Overview
Table 59. CSL Behring Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 60. CSL Behring Colloids (Blood Plasma) Product Offerings
Table 61. CSL Behring Recent Development
Table 62. Baxter Company Information
Table 63. Baxter Introduction and Business Overview
Table 64. Baxter Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 65. Baxter Colloids (Blood Plasma) Product Offerings
Table 66. Baxter Recent Development
Table 67. Grifols Company Information
Table 68. Grifols Introduction and Business Overview
Table 69. Grifols Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 70. Grifols Colloids (Blood Plasma) Product Offerings
Table 71. Grifols Recent Development
Table 72. Octapharma Company Information
Table 73. Octapharma Introduction and Business Overview
Table 74. Octapharma Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 75. Octapharma Colloids (Blood Plasma) Product Offerings
Table 76. Octapharma Recent Development
Table 77. Kedrion Company Information
Table 78. Kedrion Introduction and Business Overview
Table 79. Kedrion Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 80. Kedrion Colloids (Blood Plasma) Product Offerings
Table 81. Kedrion Recent Development
Table 82. Shanghai Raas Company Information
Table 83. Shanghai Raas Introduction and Business Overview
Table 84. Shanghai Raas Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 85. Shanghai Raas Colloids (Blood Plasma) Product Offerings
Table 86. Shanghai Raas Recent Development
Table 87. CTBB Company Information
Table 88. CTBB Introduction and Business Overview
Table 89. CTBB Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 90. CTBB Colloids (Blood Plasma) Product Offerings
Table 91. CTBB Recent Development
Table 92. Hualan Bio Company Information
Table 93. Hualan Bio Introduction and Business Overview
Table 94. Hualan Bio Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 95. Hualan Bio Colloids (Blood Plasma) Product Offerings
Table 96. Hualan Bio Recent Development
Table 97. Rongsheng Pharmaceutical Company Information
Table 98. Rongsheng Pharmaceutical Introduction and Business Overview
Table 99. Rongsheng Pharmaceutical Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 100. Rongsheng Pharmaceutical Colloids (Blood Plasma) Product Offerings
Table 101. Rongsheng Pharmaceutical Recent Development
Table 102. Boya Rongsheng Company Information
Table 103. Boya Rongsheng Introduction and Business Overview
Table 104. Boya Rongsheng Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 105. Boya Rongsheng Colloids (Blood Plasma) Product Offerings
Table 106. Boya Rongsheng Recent Development
Table 107. B. Braun Medical Company Information
Table 108. B. Braun Medical Introduction and Business Overview
Table 109. B. Braun Medical Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 110. B. Braun Medical Colloids (Blood Plasma) Product Offerings
Table 111. B. Braun Medical Recent Development
Table 112. Fresenius Kabi Company Information
Table 113. Fresenius Kabi Introduction and Business Overview
Table 114. Fresenius Kabi Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 115. Fresenius Kabi Colloids (Blood Plasma) Product Offerings
Table 116. Fresenius Kabi Recent Development
Table 117. HOSPIRA Company Information
Table 118. HOSPIRA Introduction and Business Overview
Table 119. HOSPIRA Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 120. HOSPIRA Colloids (Blood Plasma) Product Offerings
Table 121. HOSPIRA Recent Development
Table 122. Axa parenterals Company Information
Table 123. Axa parenterals Introduction and Business Overview
Table 124. Axa parenterals Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 125. Axa parenterals Colloids (Blood Plasma) Product Offerings
Table 126. Axa parenterals Recent Development
Table 127. Fresenius Kabi (China) Company Information
Table 128. Fresenius Kabi (China) Introduction and Business Overview
Table 129. Fresenius Kabi (China) Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 130. Fresenius Kabi (China) Colloids (Blood Plasma) Product Offerings
Table 131. Fresenius Kabi (China) Recent Development
Table 132. CR Double-Crane Company Information
Table 133. CR Double-Crane Introduction and Business Overview
Table 134. CR Double-Crane Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 135. CR Double-Crane Colloids (Blood Plasma) Product Offerings
Table 136. CR Double-Crane Recent Development
Table 137. Kelun Group Company Information
Table 138. Kelun Group Introduction and Business Overview
Table 139. Kelun Group Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 140. Kelun Group Colloids (Blood Plasma) Product Offerings
Table 141. Kelun Group Recent Development
Table 142. Shandong Qidu Pharmaceutical Company Information
Table 143. Shandong Qidu Pharmaceutical Introduction and Business Overview
Table 144. Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 145. Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Product Offerings
Table 146. Shandong Qidu Pharmaceutical Recent Development
Table 147. Shandong Hualu Pharmaceutical Company Information
Table 148. Shandong Hualu Pharmaceutical Introduction and Business Overview
Table 149. Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 150. Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Product Offerings
Table 151. Shandong Hualu Pharmaceutical Recent Development
Table 152. Minsheng Pharma Company Information
Table 153. Minsheng Pharma Introduction and Business Overview
Table 154. Minsheng Pharma Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 155. Minsheng Pharma Colloids (Blood Plasma) Product Offerings
Table 156. Minsheng Pharma Recent Development
Table 157. Kanglepharm Company Information
Table 158. Kanglepharm Introduction and Business Overview
Table 159. Kanglepharm Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 160. Kanglepharm Colloids (Blood Plasma) Product Offerings
Table 161. Kanglepharm Recent Development
Table 162. Key Raw Materials Lists
Table 163. Raw Materials Key Suppliers Lists
Table 164. Colloids (Blood Plasma) Downstream Customers
Table 165. Colloids (Blood Plasma) Distributors List
Table 166. Research Programs/Design for This Report
Table 167. Key Data Information from Secondary Sources
Table 168. Key Data Information from Primary Sources
List of Figures
Figure 1. Colloids (Blood Plasma) Product Picture
Figure 2. Global Colloids (Blood Plasma) Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Colloids (Blood Plasma) Sales Value (2020-2031) & (US$ Million)
Figure 4. Global Colloids (Blood Plasma) Sales Volume (2020-2031) & (MT)
Figure 5. Global Colloids (Blood Plasma) Sales Price (2020-2031) & (USD/Kg)
Figure 6. Colloids (Blood Plasma) Report Years Considered
Figure 7. Global Colloids (Blood Plasma) Players Revenue Ranking (2024) & (US$ Million)
Figure 8. Global Colloids (Blood Plasma) Players Sales Volume Ranking (2024) & (MT)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Colloids (Blood Plasma) Revenue in 2024
Figure 10. Colloids (Blood Plasma) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 11. Natural Type Colloids (Blood Plasma) Picture
Figure 12. Synthetic Type Colloids (Blood Plasma) Picture
Figure 13. Global Colloids (Blood Plasma) Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 14. Global Colloids (Blood Plasma) Sales Value Market Share by Type, 2024 & 2031
Figure 15. Global Colloids (Blood Plasma) Sales Volume by Type (2020 VS 2024 VS 2031) & (MT)
Figure 16. Global Colloids (Blood Plasma) Sales Volume Market Share by Type, 2024 & 2031
Figure 17. Global Colloids (Blood Plasma) Price by Type (2020-2031) & (USD/Kg)
Figure 18. Product Picture of Extensive Burns
Figure 19. Product Picture of Massive Blood or Plasma Loss
Figure 20. Product Picture of Hypovolemic Shock
Figure 21. Product Picture of Others
Figure 22. Global Colloids (Blood Plasma) Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 23. Global Colloids (Blood Plasma) Sales Value Market Share by Application, 2024 & 2031
Figure 24. Global Colloids (Blood Plasma) Sales Volume by Application (2020 VS 2024 VS 2031) & (MT)
Figure 25. Global Colloids (Blood Plasma) Sales Volume Market Share by Application, 2024 & 2031
Figure 26. Global Colloids (Blood Plasma) Price by Application (2020-2031) & (USD/Kg)
Figure 27. North America Colloids (Blood Plasma) Sales Value (2020-2031) & (US$ Million)
Figure 28. North America Colloids (Blood Plasma) Sales Value by Country (%), 2024 VS 2031
Figure 29. Europe Colloids (Blood Plasma) Sales Value, (2020-2031) & (US$ Million)
Figure 30. Europe Colloids (Blood Plasma) Sales Value by Country (%), 2024 VS 2031
Figure 31. Asia Pacific Colloids (Blood Plasma) Sales Value, (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Colloids (Blood Plasma) Sales Value by Region (%), 2024 VS 2031
Figure 33. South America Colloids (Blood Plasma) Sales Value, (2020-2031) & (US$ Million)
Figure 34. South America Colloids (Blood Plasma) Sales Value by Country (%), 2024 VS 2031
Figure 35. Middle East & Africa Colloids (Blood Plasma) Sales Value, (2020-2031) & (US$ Million)
Figure 36. Middle East & Africa Colloids (Blood Plasma) Sales Value by Country (%), 2024 VS 2031
Figure 37. Key Countries/Regions Colloids (Blood Plasma) Sales Value (%), (2020-2031)
Figure 38. Key Countries/Regions Colloids (Blood Plasma) Sales Volume (%), (2020-2031)
Figure 39. United States Colloids (Blood Plasma) Sales Value, (2020-2031) & (US$ Million)
Figure 40. United States Colloids (Blood Plasma) Sales Value by Type (%), 2024 VS 2031
Figure 41. United States Colloids (Blood Plasma) Sales Value by Application (%), 2024 VS 2031
Figure 42. Europe Colloids (Blood Plasma) Sales Value, (2020-2031) & (US$ Million)
Figure 43. Europe Colloids (Blood Plasma) Sales Value by Type (%), 2024 VS 2031
Figure 44. Europe Colloids (Blood Plasma) Sales Value by Application (%), 2024 VS 2031
Figure 45. China Colloids (Blood Plasma) Sales Value, (2020-2031) & (US$ Million)
Figure 46. China Colloids (Blood Plasma) Sales Value by Type (%), 2024 VS 2031
Figure 47. China Colloids (Blood Plasma) Sales Value by Application (%), 2024 VS 2031
Figure 48. Japan Colloids (Blood Plasma) Sales Value, (2020-2031) & (US$ Million)
Figure 49. Japan Colloids (Blood Plasma) Sales Value by Type (%), 2024 VS 2031
Figure 50. Japan Colloids (Blood Plasma) Sales Value by Application (%), 2024 VS 2031
Figure 51. South Korea Colloids (Blood Plasma) Sales Value, (2020-2031) & (US$ Million)
Figure 52. South Korea Colloids (Blood Plasma) Sales Value by Type (%), 2024 VS 2031
Figure 53. South Korea Colloids (Blood Plasma) Sales Value by Application (%), 2024 VS 2031
Figure 54. Southeast Asia Colloids (Blood Plasma) Sales Value, (2020-2031) & (US$ Million)
Figure 55. Southeast Asia Colloids (Blood Plasma) Sales Value by Type (%), 2024 VS 2031
Figure 56. Southeast Asia Colloids (Blood Plasma) Sales Value by Application (%), 2024 VS 2031
Figure 57. India Colloids (Blood Plasma) Sales Value, (2020-2031) & (US$ Million)
Figure 58. India Colloids (Blood Plasma) Sales Value by Type (%), 2024 VS 2031
Figure 59. India Colloids (Blood Plasma) Sales Value by Application (%), 2024 VS 2031
Figure 60. Colloids (Blood Plasma) Industrial Chain
Figure 61. Colloids (Blood Plasma) Manufacturing Cost Structure
Figure 62. Channels of Distribution (Direct Sales, and Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What is the annual compound growth rate of the global Colloids (Blood Plasma) market size from 2025 to 2031?
The annual compound growth rate of the global Colloids (Blood Plasma) market is -2.5% 2025 to 2031.
What was the global market size of Colloids (Blood Plasma) in 2025?
Which companies rank high in the global Colloids (Blood Plasma) market?
Which region is expected to have the highest market share?
What was the global market size of Colloids (Blood Plasma) in 2031?
Related Reports
Global Colloids (Blood Plasma) Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Colloids (Blood Plasma) market size was US$ 378 million in 2025 and is forecast to reach a readjusted size of US$ 317 million by 2032 with a CAGR of -2.5% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 114
USD 4250.00
(Single User License)
Global Colloids (Blood Plasma) Market Research Report 2026
The global Colloids (Blood Plasma) market was valued at US$ 378 million in 2025 and is anticipated to reach US$ 317 million by 2032, at a CAGR of -2.5% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 143
USD 2900.00
(Single User License)
Colloids (Blood Plasma)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Colloids (Blood Plasma) was estimated to be worth US$ 378 million in 2025 and is projected to reach US$ 317 million, growing at a CAGR of -2.5% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 167
USD 3950.00
(Single User License)
Global Colloids (Blood Plasma) Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Colloids (Blood Plasma) market is projected to grow from US$ 387 million in 2024 to US$ 325 million by 2031, at a CAGR of -2.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 189
USD 4900.00
(Single User License)
Global Colloids (Blood Plasma) Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Colloids (Blood Plasma) was estimated to be worth US$ 387 million and is forecast to reach approximately US$ 325 million by 2031 with a CAGR of -2.5% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 196
USD 5900.00
(Single User License)
Global Colloids (Blood Plasma) Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Colloids (Blood Plasma) market size was US$ 387 million in 2024 and is forecast to a readjusted size of US$ 325 million by 2031 with a CAGR of -2.5% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 119
USD 4250.00
(Single User License)
Global Colloids (Blood Plasma) Market Research Report 2025
The global market for Colloids (Blood Plasma) was valued at US$ 387 million in the year 2024 and is projected to reach a revised size of US$ 325 million by 2031, growing at a CAGR of -2.5% during the forecast period.
Published Date: 2025-01-16
Pages: 115
USD 2900.00
(Single User License)
Global Colloids (Blood Plasma) Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Colloids (blood plasma) are the substances of expanding the circulating blood volume, which mainly contain albumin type, gelatin type, dextran type and hydroxyethyl starch type.
Published Date: 2024-04-17
Pages: 202
USD 5600.00
(Single User License)
Global Colloids (Blood Plasma) Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Colloids (blood plasma) are the substances of expanding the circulating blood volume, which mainly contain albumin type, gelatin type, dextran type and hydroxyethyl starch type.
Published Date: 2024-04-16
Pages: 192
USD 5900.00
(Single User License)
Global Colloids (Blood Plasma) Market Insights, Forecast to 2030
Colloids (blood plasma) are the substances of expanding the circulating blood volume, which mainly contain albumin type, gelatin type, dextran type and hydroxyethyl starch type.
Published Date: 2024-04-07
Pages: 125
USD 4900.00
(Single User License)
Global Colloids (Blood Plasma) Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Colloids (Blood Plasma) market size was US$ 378 million in 2025 and is forecast to reach a readjusted size of US$ 317 million by 2032 with a CAGR of -2.5% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 114
USD 4250.00 (Single User License)Global Colloids (Blood Plasma) Market Research Report 2026
The global Colloids (Blood Plasma) market was valued at US$ 378 million in 2025 and is anticipated to reach US$ 317 million by 2032, at a CAGR of -2.5% from 2026 to 2032.
Published: 2026-01-04
Pages: 143
USD 2900.00 (Single User License)Colloids (Blood Plasma)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Colloids (Blood Plasma) was estimated to be worth US$ 378 million in 2025 and is projected to reach US$ 317 million, growing at a CAGR of -2.5% from 2026 to 2032.
Published: 2026-01-04
Pages: 167
USD 3950.00 (Single User License)Global Colloids (Blood Plasma) Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Colloids (Blood Plasma) market is projected to grow from US$ 387 million in 2024 to US$ 325 million by 2031, at a CAGR of -2.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 189
USD 4900.00 (Single User License)Global Colloids (Blood Plasma) Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Colloids (Blood Plasma) was estimated to be worth US$ 387 million and is forecast to reach approximately US$ 325 million by 2031 with a CAGR of -2.5% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 196
USD 5900.00 (Single User License)Global Colloids (Blood Plasma) Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Colloids (Blood Plasma) market size was US$ 387 million in 2024 and is forecast to a readjusted size of US$ 325 million by 2031 with a CAGR of -2.5% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 119
USD 4250.00 (Single User License)Global Colloids (Blood Plasma) Market Research Report 2025
The global market for Colloids (Blood Plasma) was valued at US$ 387 million in the year 2024 and is projected to reach a revised size of US$ 325 million by 2031, growing at a CAGR of -2.5% during the forecast period.
Published: 2025-01-16
Pages: 115
USD 2900.00 (Single User License)Global Colloids (Blood Plasma) Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Colloids (blood plasma) are the substances of expanding the circulating blood volume, which mainly contain albumin type, gelatin type, dextran type and hydroxyethyl starch type.
Published: 2024-04-17
Pages: 202
USD 5600.00 (Single User License)Global Colloids (Blood Plasma) Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Colloids (blood plasma) are the substances of expanding the circulating blood volume, which mainly contain albumin type, gelatin type, dextran type and hydroxyethyl starch type.
Published: 2024-04-16
Pages: 192
USD 5900.00 (Single User License)Global Colloids (Blood Plasma) Market Insights, Forecast to 2030
Colloids (blood plasma) are the substances of expanding the circulating blood volume, which mainly contain albumin type, gelatin type, dextran type and hydroxyethyl starch type.
Published: 2024-04-07
Pages: 125
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now